Geneva, Switzerland – April 20, 2026 — Planetary SA (“planetary” or the “Company”), the Swiss-based full-stack fermentation company building the industrial backbone of the bioeconomy, today announced a ~USD 20 million (CHF 16 million) Series A equity financing round, supplemented by ~USD 7.5m (CHF 6 million) in credit, bringing total funding to approximately ~USD 40 million (CHF 32 million).
The round was led by Radikal Capital and Oetker Ventures, with participation from, amongst others, Royal Cosun (as previously announced), arc investors, Green Generation Fund and AgriFoodTech Venture Alliance, as well as existing investors Astanor Ventures and XAnge. This diverse syndicate (bringing together carbohydrates producers, food corporates, venture capital funds, and family offices) reflects broad confidence in planetary’s full-stack approach and support for its global ingredient commercial rollout and technology licensing strategy.
The strong interest in the round underscores a clear market shift: category leaders controlling the full value chain from process development and industrial infrastructure to product launch are emerging as the winners of the new food revolution.
On the closing this round, David Brandes, CEO and co-founder of planetary added:
“Raising capital outside AI and defense now requires far more focus and resilience than it did just a few years ago. Yet, recent geopolitical turmoil and commodity volatility only strengthen the case for a sovereign, circular, and high-quality food system: stay the course and hold the line, nothing worth building comes easy.””
planetary operates a proprietary full-stack platform spanning bioprocess design, scale-up and industrial manufacturing via its WIPO Green listed BioBlocks™ system, enabling partners to bring fermentation-based food ingredients to market efficiently.
At the core of its IP-rich strategy sits the global licensing of its technology to agro-industrial players, particularly sugar companies, enabling the conversion of low-value side streams into high-value proteins, fibers and enzymes, unlocking a new circular bioeconomy.
The company has demonstrated strong commercial traction. Following the nationwide launch of its mycoprotein filet with ALDI Suisse at price parity, the company is now rolling out additional launches across Europe under its B2B brand Libre® across alternative meat and dairy, meat hybrid products, fiber-rich products and protein fortification applications.
planetary is also expanding its sugar-to-protein upcycling technology globally, including initiatives to enable ultra-low-cost mycoprotein production below $1/kg through partnerships with agro-industrial players in sucrose-rich and protein-deficient geographies, such as India.
With industrial-scale production already operational in Aarberg, Switzerland and a growing pipeline of licensing partnerships, planetary is positioning itself as a central technology layer for the fermentation economy.
The company welcomes discussions with engineers, commercial leaders and product innovators interested in joining a category-defining company, as well as with customers seeking to co-develop the next-generation food products. In addition, planetary will selectively engage with mission-aligned investors interested in participating in a second closing of the round, planned for later this summer.
Media Contact- PR@planetarygroup.ch
About XAnge - XAnge is a B Corp-certified early-stage investment fund with €800M under management and offices in Paris, Berlin and Brussels. The fund backs European founders aiming to transform everyday life through technology, investing between €1 million and €15 million from seed through Series C. XAnge invests in Deep Tech (Aerospacelab, Ledger), SaaS (Odoo, 360Learning, Skello), AI (Gleamer, Tomorro), energy transition (Greenly, GreenFusion), digital finance (Lydia) and healthcare. XAnge is the venture capital brand of the Siparex group.
